Gonadotrophic pituitary incidentaloma as the cause premature ovarian insufficiency

Cover Page

Abstract


Objective: evaluate clinical significance pituitary incidentalomas, apparently derived from gonadotropocytes.

Design: follow-up study. Patients. Three observations of pituitary microadenomas in patients whose cause for treatment was prolonged amenorrhea. Diagnosed uterine hypoplasia, decreased ovarian reserve, decreased bone mass. Patients combined expressed psycho-emotional symptoms (depression, neuroticism up to mental disorders in one case). The diagnosis of a gonadotrophic incidentaloma is suspected after exclusion of clinical and laboratory signs of prolactinoma, somatotrophic, corticotrophic and thyrotrophic adenoma.

Results. In two cases, the clinical picture of severe estrogenic failure was combined with high concentrations FSH, LH and low concentrations of anti-mullerian hormone (AMH). The increase in gonadotrophines, obviously, was both a reaction to a decreased production of estrogens, and the result of their hypersecretion by adenoma. In the observed cases there was no development of ovarian cysts, characteristic for patients with gonadotrophic adenomas, which can be explained by a reduced ovarian reserve. In the third case marked initially normal secretion of FSH and LH, not corresponding to a low concentration of sex steroids. Further there was a complete cessation of the secretion of FSH and LH with a simultaneous rapid decrease in the secretion of AMH. Given the small size of adenomas, in all cases selection of tactics for dynamic observation. All patients were prescribed hormone replacement therapy.

Conclusion. For patients with premature ovarian failure, it is advisable to carry out MRI with contrast enhancement to exclude pituitary adenoma.


Margarita A. Repina

Author for correspondence.
rectorat@spbmapo.ru
North-Western State Medical University named after I.I. Mechnikov
Russian Federation, Saint Petersburg

MD, Professor, Department of Reproductive Health of Women

  • Freda PU, Beckers AM, Katznelson L, et al.; Endocrine Society. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894-904. doi: 10.1210/jc.2010-1048.
  • Yuen KC, Cook DM, Sahasranam P, et al. Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels. Clin Endocrinol. 2008;69(2):292-8. doi: 10.1111/j.1365-2265.2008.03201.x.
  • Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001;8(4):287-305.
  • Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 2006;91(12):4769-75. doi: 10.1210/jc.2006-1668.
  • Daly AF, Burlacu MC, Livadariu E, Beckers A. The epidemiology and management of pituitary incidentalomas. Horm Res. 2007;68 Suppl 5:195-8. doi: 10.1159/000110624.
  • Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol. 2010;72(3):377-82. doi: 10.1111/j.1365-2265.2009.03667.x.
  • Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol. 2006;154(5):753-8. doi: 10.1530/eje.1.02107.
  • Cho HJ, Kim H, Kwak YJ, et al. Clinicopathologic analysis of pituitary adenoma: a single institute experience. J Korean Med Sci. 2014;29(3):405-10. doi: 10.3346/jkms.2014.29.3.405.
  • Raappana A, Koivukangas J, Ebeling T, Pirilä T. Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrin Metab. 2010;95(9):4268-75. doi: 10.1210/jc.2010-0537.
  • Caputo C, Sutherland T, Farish S, et al. Gender differences in presentation and outcome of nonfunctioning pituitary macroadenomas. Clin Endocrinol. 2013;78(4):564-70. doi: 10.1111/cen.12009.
  • Ferrante E, Ferraroni M, Castrignanò T, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006;155(6):823-9. doi: 10.1530/eje.1.02298.
  • Sivakumar W, Chamoun R, Nguyen V, Couldwell WT. Incidental pituitary adenomas. Neurosurg Focus. 2011;31(6):E18. doi: 10.3171/2011.9.FOCUS11217.
  • Chaidarun SS, Klibanski A. Gonadotropinomas. Semin Reprod Med. 2002;20(4):339-48. doi: 10.1055/s-2002-36708.
  • Chanson P, Brochier S. Non-functioning pituitary adenomas. J Endocrinol Invest. 2005;28(11 Suppl. international):93-9.
  • Krysiak R, Okopien B, Korzekwa M. Atypical pituitary tumors. Pol Merkur Lekarski. 2012;32:323-8.
  • Shimon I, Rubinek T, Bar-Nava I, et al. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone secreting pituitary adenoma. J Clin Endocrinol Metab. 2001;86(8):3635-3640. doi: 10.1210/jcem.86.8.7766.
  • Djerassi A, Coutifaris C, West VA, et al. Gonadotroph adeno ma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab. 1995;80(2):591-4. doi: 10.1210/jcem.80.2.7852525.
  • Snyder PJ. Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas. UpToDate, 2017. Available from: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-gonadotroph-and-other-clinically-nonfunctioning-pituitary-adenomas.
  • Castelbaum AJ, Bigdeli H, Post KD, et al. Exacerbation of ovarian hyperstimulation by Leuprolide reveals a gonadotroph adenoma. Fertil Steril. 2002;78(6):1311-3. doi: 10.1016/S0015-0282(02)04342-X.
  • Tashiro H, Katabuchi H, Ohtake H, et al. A follicle-stimulating hormone-secreting gonadotroph adenoma with ovarian enlargement in a 10-year old girl. Fertil Steril. 1999;72(1):158-60. doi: 10.1016/S0015-0282(99)00197-1.
  • Gryngarten MG, Braslavsky D, Ballerini MG, et al. Sponta neous ovarian hyperstimulation syndrome caused by a follicle-stimulating hormone-secreting pituitary macro adenoma in an early pubertal girl. Horm Res Paediatr. 2010;73(4):293-8. doi: 10.1159/000284395.
  • Papanicolaou A, Michala L. Autonomous ovarian cysts in prepubertal girls. A review of the literature. J Pediatr Adolesc Gynecol. 2015;28(5):292-6. doi: 10.1016/j.jpag.2015.05.004.
  • Ntali G, Capatina C, Grossman A, Karavitaki N. Clinical review: Functioning gonadotroph adenomas. J Clin Endocrinol Metab. 2014;99(12):4423-33. doi: 10.1210/jc.2014-2362.
  • Anasti JN, Flack MR, Froehlich J, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metabol. 1995;80(1):276-9.
  • Chamoun R, Layfield L, Couldwell WT. Gonadotroph adenoma with secondary hypersecretion of testosterone. World Neurosurg. 2013;80(6):900.e7-11. doi: 10.1016/j.wneu.2012.11.069.
  • Katznelson L, Alexander JM, Klibanski A. Clinically non-functioning pituitary adenomas. J Clin Endocrin Metab. 1993;76(3):1089-94.
  • Snyder PJ. Gonadotroph adenomas. In: S. Melmed, ed. Pituitary. 2nd ed. Malden: Blackwell Science Inc.; 2002.
  • Jaffe CA. Clinically non-functioning pituitary adenoma. Pituitary. 2006;9(4):317-21. doi: 10.1007/s11102-006-0412-9.
  • Colao A, Di Somma C, Pivonello R, et al. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer. 2008;15(4):905-15. doi: 10.1677/ERC-08-0181.

Views

Abstract - 24

PDF (Russian) - 54

PlumX


Copyright (c) 2018 Repina M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.